Each rat was given three attempts of three minutes on the revolving rod on the day of the test
Earlier on Wednesday, Reuters reported that among early adopters of Novo Nordisks new Wegovy weight-loss pill, 36% had never previously used a GLP-1 medication, according to a new study by the health data firm Truveta
Recently, the first oral GLP-1 agonist called Rybelsus (semaglutide) was approved by the FDA
For sealed vials, product-specific labeling applies
You're mobilizing fat-soluble toxins, inflammatory metabolites, and oxidative byproducts that were safely sequestered in adipose tissue
Maybe you saw it listed as a possible side effect, your healthcare provider mentioned it, or you're already dealing with it firsthand